Eversept Partners
Latest statistics and disclosures from Eversept Partners's latest quarterly 13F-HR filing:
- Top 5 stock holdings are QQQ, UTHR, GSK, NTRA, VERA, and represent 35.00% of Eversept Partners's stock portfolio.
- Added to shares of these 10 stocks: UTHR (+$88M), QURE (+$51M), ABVX (+$36M), QQQ (+$35M), DHR (+$15M), PODD (+$14M), RNA (+$13M), VERA (+$12M), NVO (+$12M), RGEN (+$12M).
- Started 30 new stock positions in BIIB, ARDX, ISRG, KURA, RVP, KRRO, TYRA, ATYR, SRZN, BVS.
- Reduced shares in these 10 stocks: NTRA (-$45M), INSP (-$21M), IQV (-$15M), PTGX (-$15M), MIRM (-$13M), RVTY (-$10M), GMED (-$10M), HQY (-$9.8M), SNDX (-$9.2M), MRUS (-$7.8M).
- Sold out of its positions in ARCT, AUTL, GKOS, GMED, INSP, IQV, Iteos Therapeutics, KPTI, Modivcare, PTGX. PBYI, TMO, ACIU.
- Eversept Partners was a net buyer of stock by $213M.
- Eversept Partners has $1.5B in assets under management (AUM), dropping by 33.46%.
- Central Index Key (CIK): 0001697013
Tip: Access up to 7 years of quarterly data
Positions held by Eversept Partners consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Eversept Partners
Eversept Partners holds 85 positions in its portfolio as reported in the September 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Invesco Qqq Tr Unit Ser 1 Put Option (QQQ) | 9.5 | $138M | +33% | 230k | 600.37 |
|
| United Therapeutics Corporation (UTHR) | 7.8 | $113M | +353% | 269k | 419.21 |
|
| GSK Sponsored Adr (GSK) | 6.3 | $92M | -5% | 2.1M | 43.16 |
|
| Natera (NTRA) | 5.8 | $84M | -34% | 520k | 160.97 |
|
| Vera Therapeutics Cl A (VERA) | 5.6 | $82M | +17% | 2.8M | 29.06 |
|
| Syndax Pharmaceuticals (SNDX) | 3.7 | $53M | -14% | 3.5M | 15.38 |
|
| Vaxcyte (PCVX) | 3.5 | $51M | +9% | 1.4M | 36.02 |
|
| Uniqure Nv SHS (QURE) | 3.5 | $51M | NEW | 877k | 58.37 |
|
| Hca Holdings (HCA) | 3.3 | $48M | +11% | 112k | 426.20 |
|
| Miragen Therapeutics (VRDN) | 2.9 | $42M | 1.9M | 21.58 |
|
|
| Zimvie (ZIMV) | 2.7 | $39M | 2.1M | 18.94 |
|
|
| Abivax Sa Sponsored Ads (ABVX) | 2.5 | $36M | NEW | 427k | 84.90 |
|
| Ionis Pharmaceuticals (IONS) | 2.4 | $35M | -8% | 539k | 65.42 |
|
| PerkinElmer (RVTY) | 2.4 | $35M | -22% | 394k | 87.65 |
|
| Travere Therapeutics (TVTX) | 2.3 | $34M | +7% | 1.4M | 23.90 |
|
| Bio-techne Corporation (TECH) | 2.3 | $33M | +50% | 592k | 55.63 |
|
| Celldex Therapeutics Com New (CLDX) | 2.1 | $30M | +37% | 1.2M | 25.87 |
|
| Teva Pharmaceutical Inds Sponsored Ads (TEVA) | 1.9 | $28M | +29% | 1.4M | 20.20 |
|
| Bruker Corporation (BRKR) | 1.5 | $22M | -18% | 687k | 32.49 |
|
| Community Health Systems (CYH) | 1.5 | $22M | +13% | 7.0M | 3.21 |
|
| UnitedHealth (UNH) | 1.5 | $22M | +3% | 63k | 345.30 |
|
| Danaher Corporation (DHR) | 1.4 | $20M | +323% | 99k | 198.26 |
|
| Geron Corporation (GERN) | 1.2 | $17M | +72% | 13M | 1.37 |
|
| Anthem (ELV) | 1.0 | $15M | +137% | 45k | 323.12 |
|
| Insulet Corporation (PODD) | 1.0 | $14M | NEW | 46k | 308.73 |
|
| Repligen Corporation (RGEN) | 1.0 | $14M | +464% | 105k | 133.67 |
|
| Newamsterdam Pharma Company Ordinary Shares (NAMS) | 1.0 | $14M | +17% | 489k | 28.44 |
|
| Avidity Biosciences Ord (RNA) | 0.9 | $13M | NEW | 303k | 43.57 |
|
| Novo-nordisk A S Adr (NVO) | 0.8 | $12M | NEW | 218k | 55.49 |
|
| Illumina (ILMN) | 0.8 | $12M | -37% | 124k | 94.97 |
|
| Avantor (AVTR) | 0.8 | $12M | -39% | 924k | 12.48 |
|
| Liquidia Corporation Com New (LQDA) | 0.8 | $11M | +35% | 486k | 22.74 |
|
| Mannkind Corp Com New (MNKD) | 0.8 | $11M | +192% | 2.0M | 5.37 |
|
| BioCryst Pharmaceuticals (BCRX) | 0.7 | $10M | +13% | 1.4M | 7.59 |
|
| Silverback Therapeutics (SPRY) | 0.7 | $9.8M | NEW | 977k | 10.05 |
|
| Icon SHS (ICLR) | 0.7 | $9.6M | -14% | 55k | 175.00 |
|
| Regeneron Pharmaceuticals (REGN) | 0.6 | $9.4M | +26% | 17k | 562.27 |
|
| Evolus (EOLS) | 0.6 | $9.1M | +26% | 1.5M | 6.14 |
|
| Edgewise Therapeutics (EWTX) | 0.6 | $8.1M | +27% | 502k | 16.22 |
|
| Centene Corporation (CNC) | 0.6 | $8.0M | -43% | 225k | 35.68 |
|
| BioMarin Pharmaceutical (BMRN) | 0.5 | $7.9M | NEW | 147k | 54.16 |
|
| Ardelyx (ARDX) | 0.5 | $7.9M | NEW | 1.4M | 5.51 |
|
| Biogen Idec (BIIB) | 0.5 | $7.3M | NEW | 52k | 140.08 |
|
| Catalyst Pharmaceutical Partners (CPRX) | 0.5 | $6.9M | NEW | 351k | 19.70 |
|
| Dynavax Technologies Corp Com New (DVAX) | 0.5 | $6.9M | -42% | 694k | 9.93 |
|
| Intuitive Surgical Com New (ISRG) | 0.4 | $6.5M | NEW | 14k | 447.23 |
|
| 89bio (ETNB) | 0.4 | $5.8M | +66% | 392k | 14.70 |
|
| Healthequity (HQY) | 0.3 | $5.0M | -66% | 52k | 94.77 |
|
| Structure Therapeutics Sponsored Ads (GPCR) | 0.3 | $4.7M | +67% | 166k | 28.00 |
|
| Merus N V (MRUS) | 0.3 | $4.5M | -63% | 48k | 94.15 |
|
| Alector (ALEC) | 0.3 | $4.4M | -25% | 1.5M | 2.96 |
|
| Humana (HUM) | 0.3 | $4.3M | -61% | 17k | 260.17 |
|
| Rapport Therapeutics (RAPP) | 0.3 | $4.3M | NEW | 144k | 29.70 |
|
| Tyra Biosciences (TYRA) | 0.3 | $3.8M | NEW | 273k | 13.99 |
|
| Mirum Pharmaceuticals (MIRM) | 0.2 | $3.6M | -78% | 49k | 73.31 |
|
| Zenas Biopharma (ZBIO) | 0.2 | $3.5M | -51% | 159k | 22.20 |
|
| ACADIA Pharmaceuticals (ACAD) | 0.2 | $3.5M | NEW | 164k | 21.34 |
|
| Bioventus Com Cl A (BVS) | 0.2 | $2.9M | NEW | 434k | 6.69 |
|
| Nektar Therapeutics Com New (NKTR) | 0.2 | $2.8M | -56% | 50k | 56.90 |
|
| Amarin Corp Sponsored Adr (AMRN) | 0.2 | $2.7M | 167k | 16.38 |
|
|
| Relay Therapeutics (RLAY) | 0.2 | $2.5M | -10% | 479k | 5.22 |
|
| Gossamer Bio (GOSS) | 0.2 | $2.4M | -45% | 925k | 2.63 |
|
| Kura Oncology (KURA) | 0.2 | $2.3M | NEW | 264k | 8.85 |
|
| Inflarx Nv (IFRX) | 0.2 | $2.3M | +5% | 1.7M | 1.34 |
|
| Adagio Therapeutics (IVVD) | 0.2 | $2.3M | NEW | 2.0M | 1.10 |
|
| Anteris Technologies Global (AVR) | 0.2 | $2.3M | NEW | 500k | 4.50 |
|
| Novavax Com New (NVAX) | 0.1 | $2.1M | NEW | 243k | 8.67 |
|
| Arcutis Biotherapeutics (ARQT) | 0.1 | $2.1M | NEW | 112k | 18.85 |
|
| Sutro Biopharma (STRO) | 0.1 | $2.0M | 2.3M | 0.87 |
|
|
| Fortrea Hldgs Common Stock (FTRE) | 0.1 | $1.8M | 219k | 8.42 |
|
|
| Molina Healthcare (MOH) | 0.1 | $1.8M | -54% | 9.5k | 191.36 |
|
| Contineum Therapeutics Cl A (CTNM) | 0.1 | $1.6M | NEW | 135k | 11.75 |
|
| Bicycle Therapeutics Sponsored Ads (BCYC) | 0.1 | $1.5M | -8% | 194k | 7.74 |
|
| Pliant Therapeutics (PLRX) | 0.1 | $1.2M | NEW | 825k | 1.48 |
|
| Korro Bio (KRRO) | 0.1 | $999k | NEW | 21k | 47.89 |
|
| Surrozen Com New (SRZN) | 0.1 | $992k | NEW | 77k | 12.88 |
|
| Pennant Group (PNTG) | 0.1 | $958k | 38k | 25.22 |
|
|
| Maravai Lifesciences Hldgs I Com Cl A (MRVI) | 0.1 | $834k | -54% | 291k | 2.87 |
|
| Palvella Therapeutics Inc Ne (PVLA) | 0.0 | $711k | NEW | 11k | 62.69 |
|
| eHealth (EHTH) | 0.0 | $553k | 128k | 4.31 |
|
|
| Atyr Pharma Com New Put Option (ATYR) | 0.0 | $475k | NEW | 658k | 0.72 |
|
| Retractable Technologies (RVP) | 0.0 | $306k | NEW | 363k | 0.84 |
|
| Replimune Group (REPL) | 0.0 | $251k | NEW | 60k | 4.19 |
|
| Ceribell (CBLL) | 0.0 | $196k | NEW | 17k | 11.49 |
|
| Dyne Therapeutics (DYN) | 0.0 | $127k | NEW | 10k | 12.65 |
|
Past Filings by Eversept Partners
SEC 13F filings are viewable for Eversept Partners going back to 2017
- Eversept Partners 2025 Q3 filed Nov. 14, 2025
- Eversept Partners 2025 Q2 filed Aug. 14, 2025
- Eversept Partners 2025 Q1 filed May 15, 2025
- Eversept Partners 2024 Q4 filed Feb. 14, 2025
- Eversept Partners 2024 Q3 filed Nov. 14, 2024
- Eversept Partners 2024 Q2 filed Aug. 14, 2024
- Eversept Partners 2024 Q1 filed May 15, 2024
- Eversept Partners 2023 Q4 filed Feb. 14, 2024
- Eversept Partners 2023 Q3 filed Nov. 14, 2023
- Eversept Partners 2017 Q4 restated filed Nov. 8, 2023
- Eversept Partners 2018 Q1 restated filed Nov. 8, 2023
- Eversept Partners 2018 Q2 restated filed Nov. 8, 2023
- Eversept Partners 2018 Q3 restated filed Nov. 8, 2023
- Eversept Partners 2018 Q4 restated filed Nov. 8, 2023
- Eversept Partners 2019 Q1 restated filed Nov. 8, 2023
- Eversept Partners 2019 Q2 restated filed Nov. 8, 2023